Takeda blesses a little biotech’s engineered toxin tech for multiple myeloma, triggering a bases loaded home run

Austin-based Molecular Templates scored three times on Wednesday. 

Early in the day the biotech announced a deal with Takeda to take their 2-year preclinical odyssey up to the proverbial next level, angling to take an engineered toxin tech into the clinic.